Measurement of glycine in human prefrontal brain by point-resolved spectroscopy at 7.0 tesla in vivo

17Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Measurement of glycine in human frontal brain by an optimized point-resolved spectroscopy sequence at 7 T is reported. Echo time dependencies of the overlapping coupled resonances of myo-inositol, free choline, and threonine were investigated with density matrix simulations, incorporating the slice-selective radiofrequency and gradient pulses. The numerical simulations indicated that the selectivity of the 3.55-ppm glycine singlet is maximized at (TE1, TE2) = (101, 51) ms. Phantom experiments indicated that the myo-inositol peak amplitude between 3.5 and 3.6 ppm is reduced by a factor of 30 following the optimized point-resolved spectroscopy, as predicted by the simulation. From LCModel analyses, the glycine concentration in the medial prefrontal cortex in healthy adults was estimated, with a mean Cramér-Rao lower bound of 7 ± 1% (mean ± standard deviation; n = 7), to be 0.8 ± 0.1 mM, with reference to total creatine at 8 mM. © 2009 Wiley-Liss, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Choi, C., Douglas, D., Hawesa, H., Jindal, A., Storey, C., & Dimitrov, I. (2009). Measurement of glycine in human prefrontal brain by point-resolved spectroscopy at 7.0 tesla in vivo. Magnetic Resonance in Medicine, 62(5), 1305–1310. https://doi.org/10.1002/mrm.22125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free